|
![](https://webarchive.library.unt.edu/eot2008/20081012203657im_/http://www.cdc.gov/navimages/spacer.gif) |
ICEID
2002 Webcast
Presentations
by Agents/Diseases
Note:
ICEID sessions that are not agent or disease-specific can be found on
our other listings.
A
B C D E
F G H
I J
K L
M N
O P
Q R
S T
U V
W X
Y Z
Presentations
by Agents/Diseases
A-F
|
Acute
Febrile Illness
|
Surveillance
for Patients with Acute Febrile Illness in Egypt
Salma Afifi, U.S. Naval Medical Research Unit No. 3,
Cairo, Egypt |
Acute
Respiratory Virus
|
Acute Respiratory
Virus Surveillance in Cairo and Alexandria, Egypt, July 2000-June
2001
Diaa Salman, U.S. Naval Medical Research Unit No 3.,
Cairo, Egypt |
Anaerobic
Bacteria
|
Intestinal
Anaerobic Bacteria in Early Rheumatoid Arthritis
Paavo Toivanen, Turku University, Turku, Finland
|
Anthrax |
Anthrax in the U.S. Postal System
Michele Pearson, CDC, Atlanta, GA
An
Anthrax Outbreak Averted: Public Health Response to a Contaminated
Envelope on Capitol Hill, Washington, DC, 2001
V.P. Hsu, CDC, Atlanta, GA
Anthrax
Vaccines
Arthur Friedlander, U.S. Army Medical Research Institute
of Infectious Diseases, Fort Detrick, MD
Cutaneous Anthrax in New York City
Marcelle Layton, New York Department of Health, New
York, NY
Importance of
Bacillus anthracis Molecular Subtyping During the Recent
Multi-State Bioterrorism-Associated Anthrax Outbreak in the
United States
A. Hoffmaster, CDC, Atlanta, GA
Inhalational
AnthraxNew York City, October-November 2001
T.H. Holtz, New York City Department of Health, New
York, NY
Inhalation Anthrax in Florida
Steve Wiersma, Florida Department of Health, Tallahassee,
FL
Inhalation Anthrax of Unknown Source
James Hadler, Connecticut Department of Public Health,
Hartford, CT
Laboratory
Response in the Commonwealth of Virginia to the Intentional
Release of Bacillus anthracis
Denise Pettit, Division of Consolidated Laboratory
Services, Richmond, VA
Letters from
Trenton: The Anthrax Investigation at the Source, New Jersey,
2001
J. Reefhuis, CDC, Atlanta, GA
Monitoring
of Human Exposure to Bacillus thuringiensis After
Aerial Applications for Insect Control
David Levin, University of Victoria, Victoria, BC,
Canada
Public
Health Laboratory Response to an Anthrax Incident in Connecticut
Donald Mayo, Connecticut State Health Department, Hartford,
CT
Rapid
Adaptation of a Serologic Assay for the Bioterrorism-Related
Anthrax OutbreakOctober-December, 2001
C.M. Greene, CDC, Atlanta, GA
Rapid
Molecular Identification of B. anthracis in New York
State in Response to Recent Bioterrorism Incidents
Kimberlee Musser, New York, State Department of Health,
Albany, NY
|
Astrovirus |
Incidence
and Type Distribution of Astrovirus Among Spanish Children
Alicia Sánchez-Fauquier, Centro Nacional de MicrobiologĂa,
Madrid, Spain |
Bacillus
thuringiensis |
Monitoring
of Human Exposure to Bacillus thuringiensis After Aerial
Applications for Insect Control
David Levin, University of Victoria, Victoria, BC, Canada
|
Botulism |
An Evaluation
of an Educational Videotape to Prevent Botulism among Alaska
Natives
Catherine Dentinger, CDC, Anchorage, AK |
Bovine
Spongiform Encephalopathy (BSE) and Creutzfeldt-Jakob Disease
(CJD) |
The
Agent: Prions as Emerging Infectious Particles
David Bolton, New York State Institute for Basic Research,
Staten Island, NY
Impact
of the BSE/vCJD Outbreak: U.S. Concerns for TSEs
Ermias
Belay, CDC, Atlanta, GA
The
Reservoir: Bovine Spongiform Encephalopathy and What's Been
Done About It
Dagmar Heim, Swiss Federal Veterinary Office, Bern-Liebefeld,
Switzerland
The
Unfolding Variant (vCJD) Epidemic
Robert Will, Western General Hospital, Edinburgh,
United Kingdom
|
Calicivirus |
Challenges
in the Interpretation of Classical and Molecular Epidemiology
Results; Two Calicivirus Outbreaks Due to Oysters,
Denmark at New Year 2000
Francois-Xavier
Hanon, Statens Serum Institut, Copenhagen, Denmark
Coordinating
Environmental Public Health Practice with Epidemiology and
Laboratory Analysis: A Waterborne Outbreak of "Norwalk-like
Virus" in the Big Horn Mountains of Wyoming
Scott Seys, Wyoming Department of Health, Cheyenne,
WY
Transmission
of the Main Viral Pathogens Causing Gastroenteritis, NLV,
SLV, and Rotavirus
Yvonne van Duynhoven, National
Institute of Public Health and the Environment, Bilthoven,
The Netherlands
|
Campylobacter
|
The
Acquisition of Ciprofloxacin Resistance in Travel-Associated
and Home-Acquired Campylobacter jejuni Infection: A
Case-Case Comparison
Iain Gillespie, Public Health Laboratory Service, London,
United Kingdom
Campylobacter
coliWhat’s the Big
Deal?
Sarah O'Brien, Public Health Laboratory Service, London,
United Kingdom
Prevalence
and Consequences of Fluoroquinolone-Resistant Campylobacter
Infections: NARMS 1997-2000
Jennifer McClellan, CDC, Atlanta, GA
Prevalence
of Salmonella spp. and Campylobacter spp. Following the Discontinued Use of Antimicrobial Growth Promoters in
Broilers and Swine in Denmark
Mary Evans, Danish Veterinary Institute,
Copenhagen, Denmark
|
Chagas
Disease |
Ecological
Niche Modeling and Differentiation of Populations of Triatoma
Brasiliensis Neiva, 1911, the Most Important Chagas Disease
Vector in Northeastern Brazil (Hemiptera, Reduviidae, Triatominae)
Jane Costa, CDC, Atlanta, GA
Eradication
of Chagas Disease
Gabriel Schmunis, Pan American Health Organization,
Washington, DC
A Greenhouse
Study to Model Potential Field Use of Genetically Modified
Bacterial Symbionts for Chagas' Disease Control
Pritha Sen, CDC, Atlanta, GA
|
C.
pneumoniae |
Failure
to Detect C. pneumoniae in Atherosclerotic Specimens
Silvio Pitlik, Rabin Medical Center, Petah Tikvah, Israel
|
Cryptococcus |
Outbreak
of Cryptococcus neoformans var. gattii in
a Restricted Zone in British Columbia
Mike Starr, University of British Columbia Centre
for Disease Control, Vancouver, BC, Canada
|
Cryptosporidiosis |
Is
Drinking Water a Risk Factor for Endemic Cryptosporidiosis
in the Immunocompetent General Population of the San Francisco
Bay Area?
Asheena Khalakdina, University of California at Berkeley,
Berkeley, CA
|
Cysticercosis |
Eradication
of T. solium Cysticercosis
Peter Schantz, CDC, Atlanta, GA |
Dengue |
Bringing
Dengue Prevention Down to Earth: Evaluation of a Head Start
Project in Puerto Rico
Carmen Pérez-Guerra, CDC, San Juan, PR
Dengue Fever
Outbreak in Hawaii2001
Paul Effler, State of Hawaii Department of Health,
Honolulu, HI
Re-introduction
of Dengue 3 in Aragua, Venezuela: Clinical, Epidemiological
and Laboratory Features of a New Outbreak
Guillermo Comach, Lardidev-Biomed, Universidad de Carabobo,
Maracay, Venezuela
|
Encephalitis |
Clusters
of Clinical Syndromes in Patients with Unexplained Encephalitis
Carol Glaser, California Department of Health Services,
Berkeley, CA
Mapping
of West Nile Virus Risk in the Northeast United States Using
Multi-Temporal Meteorological Satellite Data
P. Bryon Backenson, New York State Department of Health,
Albany, NY
Microheterogenicity
of the Volgograd Clone of West Nile Virus
Alexander Platonov, Central Research Institute of Epidemiology,
Moscow, Russian Federation
Rapid
Screening and Identification of West Nile Virus in Captive
and Wild Birds Using Non-Invasive Environmental Samples and
a Portable TaqMan RT-PCR
Johnny Callahan, Tetracore, Inc., Gaithersburg, MD
West Nile Virus
First Transmission Season in Florida, 2001More Than
400 Horse Cases and 170 Chicken Seroconversions but Only Sporadic
Human Disease
Carina Blackmore, Florida Department of Health, Jacksonville,
FL
West
Nile Virus Infection
Deborah Asnis, Brooklyn, NY
West
Nile Virus in New York City
Wilfredo Lopez, New York City Department of Health,
New York, NY
|
Enterococcus
|
Quinupristin/Dalfopristin-Resistant
Enterococcus faecium Isolated from Human Stools, Retail
Chicken, and Retail Pork: EIP Enterococci Project
Kathryn Gay, CDC, Atlanta, GA |
Enterovirus |
Changes
in Circulating Enterovirus Serotypes in the United States,
2001
Andy Mullins, CDC, Atlanta, GA
Detection
and Typing of Enterovirus in Cerebrospinal Fluid
Blair Rosen, New York State Department of Health, Slingerlands,
NY
|
Escherichia
coli O157 |
Epidemiology
of Shiga Toxin-Producing Escherichia coli (STEC) Infections
in Connecticut, February 1, 2000-January 31, 2001
Q. Phan, Connecticut Department of Public Health, Hartford,
CT
High
Prevalence of Antibiotic Resistance in Enterotoxigenic
E. coli (ETEC); Minnesota 2000-2001
John Besser, Minnesota Department of Health, Minneapolis,
MN
Microbiologic
Testing to Identify Shiga Toxin-Producing E. coli in
HUS Patients: FoodNet 1997-2001
C.R. Braden, CDC, Atlanta, GA
PulseNet
Experience: Software Changes and Improvements to Online E.
coli National Database
Susan Hunter, CDC, Atlanta, GA
Real-time
Fluorescence PCR Assays for the Detection and Characterization
of Heat-Labile and Heat-Stable Enterotoxin Genes from Enterotoxigenic
Escherichia coli
Nancy Strockbine, CDC, Atlanta, GA
Risk
Factors for Sporadic Escherichia coli O157 Infections
in the United States: A Case-Control Study in FoodNet Sites,
1999-2000
M.H. Kennedy, CDC, Atlanta, GA
Three
Outbreaks of E. coli O157 Infections Due to Retail
Ground Beef in Minnesota, 2000: Detection, Investigation,
and Characteristics
Ellen Swanson, Minnesota Department of Health, Minneapolis,
MN
|
Foot
and Mouth Disease |
Foot and Mouth Disease
Christopher Bostock, Institute of Animal Health, Compton,
United Kingdom |
|
A
B C D E
F G H
I J
K L
M N
O P
Q R
S T
U V
W X
Y Z
|